R&D productivity: Drug approvals don’t tell the whole story

R&D productivity: Drug approvals don’t tell the whole story

By Zachary Brennan, 28-May-2014

As the number of drug approvals declined between 2012 and 2013 by more than 30%, the value of new therapeutic agent approvals seems to indicate a stronger year than initially thought.

http://www.in-pharmatechnologist.com/Processing/R-D-productivity-Drug-approvals-don-t-tell-the-whole-story